{"id":"https://openalex.org/W2336054546","doi":"https://doi.org/10.1182/blood.v126.23.3982.3982","title":"Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma","display_name":"Brentuximab Vedotin Plus Bendamustine: A Highly Active Salvage Treatment Regimen for Patients with Relapsed or Refractory Hodgkin Lymphoma","publication_year":2015,"publication_date":"2015-12-03","ids":{"openalex":"https://openalex.org/W2336054546","doi":"https://doi.org/10.1182/blood.v126.23.3982.3982","mag":"2336054546"},"language":"en","primary_location":{"id":"doi:10.1182/blood.v126.23.3982.3982","doi":"https://doi.org/10.1182/blood.v126.23.3982.3982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3982.3982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5085801543","display_name":"Ann Steward LaCasce","orcid":"https://orcid.org/0000-0001-7349-0176","observed_orcids":["https://orcid.org/0000-0001-7349-0176"]},"institutions":[{"id":"https://openalex.org/I4210117453","display_name":"Dana-Farber Cancer Institute","ror":"https://ror.org/02jzgtq86","country_code":"US","type":"facility","lineage":["https://openalex.org/I4210117453"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ann S. LaCasce","raw_affiliation_strings":["Dana-Farber Cancer Institute, Boston, MA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Dana-Farber Cancer Institute, Boston, MA","institution_ids":["https://openalex.org/I4210117453"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109545432","display_name":"Gregory R. Bociek","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Gregory Bociek","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5008086243","display_name":"Ahmed Sawas","orcid":"https://orcid.org/0000-0003-2448-0144","observed_orcids":["https://orcid.org/0000-0003-2448-0144"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ahmed Sawas","raw_affiliation_strings":["Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5016048836","display_name":"Paolo Fabrizio Caimi","orcid":"https://orcid.org/0000-0003-1436-0464","observed_orcids":["https://orcid.org/0000-0003-1436-0464"]},"institutions":[{"id":"https://openalex.org/I4210108791","display_name":"University Hospitals Cleveland Medical Center","ror":"https://ror.org/01gc0wp38","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799343972","https://openalex.org/I4210108791"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Paolo F. Caimi","raw_affiliation_strings":["University Hospitals Case Medical Center, Cleveland, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University Hospitals Case Medical Center, Cleveland, OH","institution_ids":["https://openalex.org/I4210108791"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109344988","display_name":"Edward D. Agura","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Edward Agura","raw_affiliation_strings":["Charles A. Sammons Cancer Center, Dallas, TX"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Charles A. Sammons Cancer Center, Dallas, TX","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5110947413","display_name":"Jeffrey Matous","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210134093","display_name":"Colorado Blood Cancer Institute","ror":"https://ror.org/040pncp85","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210134093"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Jeffrey Matous","raw_affiliation_strings":["Colorado Blood Cancer Institute, Denver, CO"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Colorado Blood Cancer Institute, Denver, CO","institution_ids":["https://openalex.org/I4210134093"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059729547","display_name":"Stephen Maxted Ansell","orcid":"https://orcid.org/0000-0003-1244-6758","observed_orcids":["https://orcid.org/0000-0003-1244-6758"]},"institutions":[{"id":"https://openalex.org/I1330342723","display_name":"Mayo Clinic","ror":"https://ror.org/02qp3tb03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1330342723"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Stephen Ansell","raw_affiliation_strings":["Mayo Clinic, Rochester, MN"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Mayo Clinic, Rochester, MN","institution_ids":["https://openalex.org/I1330342723"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5059055898","display_name":"Howland E. Crosswell","orcid":"https://orcid.org/0000-0002-2165-9889","observed_orcids":["https://orcid.org/0000-0002-2165-9889"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Howland Crosswell","raw_affiliation_strings":["Bon Secours St. Francis Hospital, Greenville, SC"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bon Secours St. Francis Hospital, Greenville, SC","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5079927356","display_name":"Miguel Islas\u2010Ohlmayer","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210165260","display_name":"Mercy Health","ror":"https://ror.org/054bs2v13","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210165260"]},{"id":"https://openalex.org/I7287704","display_name":"Jewish Hospital","ror":"https://ror.org/01h2jcs31","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210165260","https://openalex.org/I7287704"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Miguel Islas-Ohlmayer","raw_affiliation_strings":["The Jewish Hospital-Mercy Health, Cincinnati, OH"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Jewish Hospital-Mercy Health, Cincinnati, OH","institution_ids":["https://openalex.org/I4210165260","https://openalex.org/I7287704"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5051580992","display_name":"Caroline M. Behler","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"Caroline Behler","raw_affiliation_strings":["Pacific Hematology Oncology Associates, San Francisco, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pacific Hematology Oncology Associates, San Francisco, CA","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5112248789","display_name":"Eric M. Cheung","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210128239","display_name":"Oncology Institute of Hope and Innovation","ror":"https://ror.org/0346nyf55","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210128239"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Eric Cheung","raw_affiliation_strings":["The Oncology Institute of Hope and Innovation, Whittier, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"The Oncology Institute of Hope and Innovation, Whittier, CA","institution_ids":["https://openalex.org/I4210128239"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5046549002","display_name":"Andres Forero","orcid":"https://orcid.org/0000-0002-1360-1695","observed_orcids":["https://orcid.org/0000-0002-1360-1695","https://orcid.org/0000-0001-5161-8319"]},"institutions":[{"id":"https://openalex.org/I32389192","display_name":"University of Alabama at Birmingham","ror":"https://ror.org/008s83205","country_code":"US","type":"education","lineage":["https://openalex.org/I32389192"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Andres Forero-Torres","raw_affiliation_strings":["University of Alabama at Birmingham, Birmingham, AL"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Alabama at Birmingham, Birmingham, AL","institution_ids":["https://openalex.org/I32389192"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5080373697","display_name":"Julie Marie Vose","orcid":"https://orcid.org/0000-0003-1015-7434","observed_orcids":["https://orcid.org/0000-0003-1015-7434"]},"institutions":[{"id":"https://openalex.org/I59130452","display_name":"University of Nebraska Medical Center","ror":"https://ror.org/00thqtb16","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I59130452"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Julie Vose","raw_affiliation_strings":["University of Nebraska Medical Center, Omaha, NE"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"University of Nebraska Medical Center, Omaha, NE","institution_ids":["https://openalex.org/I59130452"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002126535","display_name":"Owen A. O\u2019Connor","orcid":"https://orcid.org/0000-0002-5631-0011","observed_orcids":["https://orcid.org/0000-0002-5631-0011"]},"institutions":[{"id":"https://openalex.org/I2799503643","display_name":"Columbia University Irving Medical Center","ror":"https://ror.org/01esghr10","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I2799503643"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Owen A. O'Connor","raw_affiliation_strings":["Columbia University Medical Center, New York, NY"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Columbia University Medical Center, New York, NY","institution_ids":["https://openalex.org/I2799503643"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5049442315","display_name":"Neil C. Josephson","orcid":"https://orcid.org/0000-0003-4660-542X","observed_orcids":["https://orcid.org/0000-0003-4660-542X"]},"institutions":[{"id":"https://openalex.org/I99319750","display_name":"Seagen (United States)","ror":"https://ror.org/01vwesc15","country_code":"US","type":"company","lineage":["https://openalex.org/I99319750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Neil Josephson","raw_affiliation_strings":["Seattle Genetics, Inc., Bothell, WA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Seattle Genetics, Inc., Bothell, WA","institution_ids":["https://openalex.org/I99319750"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5060314041","display_name":"Ranjana H. Advani","orcid":"https://orcid.org/0000-0002-3219-2292","observed_orcids":["https://orcid.org/0000-0002-3219-2292"]},"institutions":[{"id":"https://openalex.org/I4210137306","display_name":"Stanford Medicine","ror":"https://ror.org/03mtd9a03","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]},{"id":"https://openalex.org/I97018004","display_name":"Stanford University","ror":"https://ror.org/00f54p054","country_code":"US","type":"education","lineage":["https://openalex.org/I97018004"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Ranjana Advani","raw_affiliation_strings":["Stanford Cancer Center, Stanford, CA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Stanford Cancer Center, Stanford, CA","institution_ids":["https://openalex.org/I4210137306","https://openalex.org/I97018004"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":13,"corresponding_author_ids":["https://openalex.org/A5079927356","https://openalex.org/A5112248789"],"corresponding_institution_ids":["https://openalex.org/I4210128239","https://openalex.org/I4210165260","https://openalex.org/I7287704"],"apc_list":{"value":5500,"currency":"USD","value_usd":5500},"apc_paid":null,"fwci":10.7702,"has_fulltext":false,"cited_by_count":62,"citation_normalized_percentile":{"value":0.99020163,"is_in_top_1_percent":true,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":89,"max":100},"biblio":{"volume":"126","issue":"23","first_page":"3982","last_page":"3982"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9984999895095825,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.0006000000284984708,"subfield":{"id":"https://openalex.org/subfields/2716","display_name":"Genetics"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10685","display_name":"Viral-associated cancers and disorders","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/brentuximab-vedotin","display_name":"brentuximab vedotin","score":0.9599999785423279},{"id":"https://openalex.org/keywords/bendamustine","display_name":"bendamustine","score":1.0},{"id":"https://openalex.org/keywords/relapsed-refractory-hodgkin-lymphoma","display_name":"relapsed/refractory Hodgkin lymphoma","score":0.9350000023841858},{"id":"https://openalex.org/keywords/salvage-chemotherapy","display_name":"salvage chemotherapy","score":0.9440000057220459},{"id":"https://openalex.org/keywords/autologous-stem-cell-transplantation","display_name":"autologous stem cell transplantation","score":0.8759999871253967},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.9240000247955322},{"id":"https://openalex.org/keywords/combination-chemotherapy","display_name":"combination chemotherapy","score":0.4860000014305115},{"id":"https://openalex.org/keywords/recommended-dose","display_name":"recommended dose","score":0.5},{"id":"https://openalex.org/keywords/treatment-efficacy-and-safety","display_name":"treatment efficacy and safety","score":0.6140000224113464},{"id":"https://openalex.org/keywords/progression-free-survival","display_name":"progression-free survival","score":0.6830000281333923},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.9760000109672546},{"id":"https://openalex.org/keywords/cd30-targeted-therapy","display_name":"CD30-targeted therapy","score":0.6299999952316284},{"id":"https://openalex.org/keywords/first-relapse","display_name":"first relapse","score":0.40799999237060547},{"id":"https://openalex.org/keywords/primary-refractory-disease","display_name":"primary refractory disease","score":0.8870000243186951},{"id":"https://openalex.org/keywords/pediatric-and-adolescent-patients","display_name":"pediatric and adolescent patients","score":0.367000013589859},{"id":"https://openalex.org/keywords/dose-limiting-toxicity","display_name":"dose-limiting toxicity","score":0.4429999887943268}],"concepts":[{"id":"https://openalex.org/C2781442060","wikidata":"https://www.wikidata.org/wiki/Q425745","display_name":"Bendamustine","level":4,"score":0.9276148080825806},{"id":"https://openalex.org/C2778191690","wikidata":"https://www.wikidata.org/wiki/Q422324","display_name":"Brentuximab vedotin","level":4,"score":0.9048941135406494},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.8363562822341919},{"id":"https://openalex.org/C2780775027","wikidata":"https://www.wikidata.org/wiki/Q17141389","display_name":"Salvage therapy","level":3,"score":0.6533070802688599},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.5966854095458984},{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.5237633585929871},{"id":"https://openalex.org/C142424586","wikidata":"https://www.wikidata.org/wiki/Q7307572","display_name":"Refractory (planetary science)","level":2,"score":0.4903995990753174},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.4404102563858032},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.4022359549999237},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.3335452079772949},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.2687596082687378},{"id":"https://openalex.org/C2992779791","wikidata":"https://www.wikidata.org/wiki/Q209369","display_name":"Hodgkin lymphoma","level":3,"score":0.13664278388023376},{"id":"https://openalex.org/C2780653079","wikidata":"https://www.wikidata.org/wiki/Q412323","display_name":"Rituximab","level":3,"score":0.11324918270111084},{"id":"https://openalex.org/C87355193","wikidata":"https://www.wikidata.org/wiki/Q411","display_name":"Astrobiology","level":1,"score":0.0},{"id":"https://openalex.org/C121332964","wikidata":"https://www.wikidata.org/wiki/Q413","display_name":"Physics","level":0,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1182/blood.v126.23.3982.3982","doi":"https://doi.org/10.1182/blood.v126.23.3982.3982","is_oa":false,"landing_page_url":"https://doi.org/10.1182/blood.v126.23.3982.3982","pdf_url":null,"source":{"id":"https://openalex.org/S200071133","display_name":"Blood","issn_l":"0006-4971","issn":["0006-4971","1528-0020"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-a","doyens","jufo-3","ki-jl-3","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320990","host_organization_name":"Elsevier BV","host_organization_lineage":["https://openalex.org/P4310320990"],"host_organization_lineage_names":["Elsevier BV"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Blood","raw_type":"journal-article"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"sustainable_development_goals_aurora":[{"display_name":"Good health and well-being","score":0.7799999713897705,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W2117127505","https://openalex.org/W4250474815","https://openalex.org/W773219832","https://openalex.org/W4210806011","https://openalex.org/W2995464159","https://openalex.org/W3025425514","https://openalex.org/W4284705137","https://openalex.org/W3045653281","https://openalex.org/W2336054546","https://openalex.org/W4297913901"],"abstract_inverted_index":{"Abstract":[0],"Background":[1],"Long-term":[2],"outcomes":[3],"from":[4,30,512,529,592,601],"autologous":[5,719],"stem":[6,720],"cell":[7,447,721,751],"transplant":[8,546,722],"(ASCT)":[9],"in":[10,22,97,111,212,293,303,456,474,540,549,618,687,706,734,768,776],"patients":[11,23,712,735,746,770],"(pts)":[12],"with":[13,48,65,99,106,131,159,181,247,305,339,368,374,620,641,651,685,713,747,771],"relapsed/refractory":[14],"(R/R)":[15],"Hodgkin":[16,714],"lymphoma":[17,715,752],"(HL)":[18],"are":[19,55,737],"significantly":[20],"better":[21],"who":[24,544,553,736],"achieve":[25],"a":[26,189,248,313,324,375,475,506,633,647,679],"complete":[27,233],"remission":[28],"(CR)":[29],"salvage":[31,38,681],"chemotherapy":[32,732,761],"prior":[33,730,759],"to":[34,63,88,143,166,174,192,214,399,485],"ASCT.":[35,530],"However,":[36],"standard":[37],"therapy":[39],"produces":[40],"variable":[41],"CR":[42,71,217,407,434,636],"rates":[43],"(19%-60%)":[44],"and":[45,53,69,74,92,136,155,188,234,239,265,323,358,364,370,378,419,426,438,442,487,495,521,547,573,597,627,741,820],"is":[46,232,562,704],"associated":[47],"significant":[49,654],"toxicity.":[50],"Brentuximab":[51,702],"vedotin":[52,96,127,161,307,612,703,767],"bendamustine":[54,100,132,205,302,621],"highly":[56],"active":[57],"when":[58],"administered":[59,207],"as":[60,162],"single":[61],"agents":[62],"pts":[64,105,244,261,268,385,404,415,459,543,552,590,684],"R/R":[66],"HL":[67,596,686,769],"(34%":[68],"33%":[70],"rates,":[72],"respectively)":[73],"have":[75,502,536],"manageable":[76,648],"safety":[77,91,295,649],"profiles.":[78],"This":[79,763],"phase":[80,203],"1/2,":[81],"single-arm,":[82],"2-stage,":[83],"open-label":[84],"study":[85,764],"was":[86,172,206,223,308,342,372,412,429,436,454,467,490],"designed":[87,173],"evaluate":[89],"the":[90,102,176,198,209,216,220,226,294,298,321,340,382,410,420,541,550,566,574,583,652,677,688,707,743],"efficacy":[93],"of":[94,104,123,138,179,185,219,251,260,267,278,301,315,320,326,331,387,394,409,458,463,477,508,582,594,610,629,671,711,718,726,745,755],"brentuximab":[95,126,160,306,333,611,766],"combination":[98,304,322,341,411,619,678],"for":[101,141,164,237,402,417,440,505,564,683,709,742],"treatment":[103,158,391,400,710,744],"primary":[107,270,772],"refractory":[108,271,441,773],"disease":[109,264,272,774],"or":[110,723,775],"first":[112,513,689,777],"relapse":[113,690],"(ClinicalTrials.gov":[114],"#NCT01874054).":[115],"Methods":[116],"Pts":[117,146,311,501],"received":[118,312],"an":[119,182],"outpatient":[120,608],"IV":[121],"infusion":[122],"1.8":[124,613],"mg/kg":[125,614],"on":[128,133,615,624],"Day":[129,616],"1":[130,135,171,510,598,617,626],"Days":[134,625],"2":[137,154,316,403,478,589,628],"3-week":[139,630],"cycles":[140,317,328,631],"up":[142,165],"6":[144,384],"cycles.":[145],"could":[147],"undergo":[148,556],"ASCT":[149,739],"any":[150],"time":[151,484],"after":[152,273,449,604,716,724,753],"Cycle":[153],"post-transplant":[156],"resume":[157],"monotherapy":[163],"16":[167],"total":[168],"doses.":[169],"Phase":[170],"determine":[175],"recommended":[177,210,299],"dose":[178,184,211,300,514],"bendamustine,":[180],"initial":[183,286],"90":[186,309,622],"mg/m2":[187,623],"de-escalation":[190],"scheme":[191],"be":[193,661],"implemented":[194],"if":[195],"it":[196],"exceeded":[197],"maximum":[199],"tolerated":[200],"dose.":[201],"During":[202],"2,":[204],"at":[208,727,756],"order":[213],"assess":[215],"rate":[218,408,424,435,637,670],"combination.":[221],"Response":[222],"assessed":[224],"by":[225,664],"investigator":[227],"per":[228],"Cheson":[229],"2007.":[230],"Enrollment":[231],"long-term":[235],"follow-up":[236],"PFS":[238,561,669],"OS":[240],"continues.":[241],"Results":[242],"Fifty-five":[243],"(56%":[245,345],"female)":[246],"median":[249,277,314,325,476,507],"age":[250],"36":[252],"yrs":[253],"(range,":[254,281,318,329,479,493,498],"19-79)":[255],"were":[256,291,352,587],"enrolled.":[257],"Fifty-one":[258],"percent":[259],"had":[262,269,283],"relapsed":[263,443],"49%":[266],"frontline":[274],"therapy.":[275],"A":[276],"13.8":[279],"mos":[280,524],"3-98)":[282],"elapsed":[284],"since":[285],"diagnosis.":[287],"No":[288],"dose-limiting":[289],"toxicities":[290],"observed":[292,338],"cohort,":[296],"thus":[297],"mg/m2.":[310],"1-6)":[319],"9":[327],"1-14)":[330],"single-agent":[332],"vedotin.":[334],"The":[335,347,406,433,558,607,644,666],"main":[336],"toxicity":[337],"infusion-related":[343],"reactions":[344],"overall).":[346],"most":[348,653],"common":[349],"symptoms":[350],"(\u226510%)":[351],"pyrexia":[353],"(26%),":[354],"chills":[355],"(20%),":[356],"dyspnea":[357],"nausea":[359],"(15%":[360],"each),":[361],"flushing":[362],"(13%),":[363],"hypotension":[365],"(11%).":[366],"Premedication":[367],"corticosteroids":[369],"antihistamines":[371],"instituted":[373],"protocol":[376],"amendment":[377],"appeared":[379],"effective.":[380],"Before":[381],"amendment,":[383],"(24%":[386],"treated":[388],"pts)":[389],"discontinued":[390],"prematurely":[392],"because":[393],"IRRs;":[395],"post-amendment,":[396],"IRRs":[397,658],"led":[398],"discontinuation":[401],"(7%).":[405],"74%":[413],"(39/53":[414],"evaluable":[416],"response)":[418],"overall":[421,575],"objective":[422],"response":[423,674],"(CR":[425],"partial":[427],"remission)":[428],"93%":[430,457],"(49/53":[431],"pts).":[432],"64%":[437],"84%":[439],"pts,":[444],"respectively.":[445,500],"Stem":[446],"collection":[448],"first-line":[450],"mobilization":[451],"(G-CSF\u00b1":[452],"plerixafor)":[453],"successful":[455],"(37/40).":[460],"Median":[461,483],"number":[462],"CD34+":[464],"cells":[465],"collected":[466],"4.1":[468],"x106":[469],"(Q1,":[470],"Q3:":[471],"3.0,":[472],"5.4)":[473],"1-5)":[480],"apheresis":[481],"sessions.":[482],"neutrophil":[486],"platelet":[488],"engraftment":[489],"11":[491],"days":[492,497],"9-21)":[494],"13":[496,551],"9-39),":[499],"been":[503,537],"followed":[504],"approximately":[509,522],"year":[511],"(median":[515],"=":[516],"418":[517],"days;":[518,526],"range,":[519,527],"118-635)":[520],"10":[523],"(314":[525],"13-553)":[528],"To":[531],"date,":[532],"12":[533,584],"progression":[534,585,593],"events":[535,586],"observed:":[538],"7":[539],"40":[542],"underwent":[545],"5":[548],"did":[554],"not":[555,738],"transplant.":[557,605],"estimated":[559,667],"12-mos":[560,668],"80%":[563,672],"both":[565],"transplanted":[567],"population":[568,576],"(95%":[569,577],"CI:":[570,578],"70%,":[571],"90%)":[572],"60%,":[579],"90%).":[580],"Three":[581],"deaths;":[588],"died":[591,600],"their":[595],"pt":[599],"septic":[602],"shock":[603],"Conclusions":[606],"regimen":[609,645,682],"induced":[632],"very":[634],"high":[635],"that":[638,659],"compares":[639],"favorably":[640],"historical":[642],"data.":[643],"has":[646],"profile,":[650],"side":[655],"effect":[656],"being":[657],"can":[660],"successfully":[662],"managed":[663],"premedication.":[665],"demonstrates":[673],"durability,":[675],"making":[676],"promising":[680],"setting.":[691],"Progression-Free":[692],"Survival":[693],"Figure":[694,696],"1.":[695,697],"Disclosures":[698],"Off":[699],"Label":[700],"Use:":[701],"indicated":[705],"US":[708],"failure":[717,725,754],"least":[728,757],"two":[729],"multi-agent":[731,760],"regimens":[733],"candidates":[740],"systemic":[748],"anaplastic":[749],"large":[750],"one":[758],"regimen.":[762],"evaluates":[765],"relapse.":[778],".":[779],"Sawas:Seattle":[780],"Genetics,":[781,786,801,829,834,843,848,853,859,865],"Inc.:":[782,787,802,830,835,844,849,854,860,866],"Research":[783,788,803,809,812,826,831,836,845,850,856,867],"Funding.":[784,789,813,827,832,846,851,857],"Agura:Seattle":[785],"Matous:Takeda":[790],"Pharmaceuticals":[791],"International":[792],"Co.:":[793],"Speakers":[794,798,805,840],"Bureau;":[795,799],"Celgene:":[796],"Consultancy,":[797],"Seattle":[800],"Funding,":[804],"Bureau.":[806,841],"Ansell:Bristol-Myers":[807],"Squibb:":[808],"Funding;":[810,837,868],"Celldex:":[811],"Crosswell:KIYATEC":[814],"(employment);":[815],"Gilead":[816],"(common":[817],"stock":[818],"ownership":[819],"research":[821],"funding):":[822],"Employment,":[823,861],"Equity":[824,862],"Ownership,":[825],"Islas-Ohlmayer:Seattle":[828],"Behler:Seattle":[833],"Onyx":[838],"Pharmaceuticals:":[839],"Cheung:Seattle":[842],"Forero-Torres:Seattle":[847],"Vose:Seattle":[852],"Honoraria,":[855],"Josephson:Seattle":[858],"Ownership.":[863],"Advani:Seattle":[864],"Genetech:":[869],"Consultancy.":[870]},"counts_by_year":[{"year":2026,"cited_by_count":2},{"year":2022,"cited_by_count":3},{"year":2021,"cited_by_count":2},{"year":2020,"cited_by_count":6},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":18},{"year":2017,"cited_by_count":20},{"year":2016,"cited_by_count":9},{"year":2014,"cited_by_count":1}],"updated_date":"2026-10-16T09:59:22.235173","created_date":"2025-10-10T00:00:00"}